Paper Tools Add to my Library Share How would you like to share? Facebook Twitter LinkedIn Back to the Top
Page S. Counting costs. Patients will suffer from limits on Alzheimer's drugs. Nurs Stand. 2005 May 25-31;19(37):24-5. PubMed. Recommends Please login to recommend the paper. Comments John Trojanowski University of Pennsylvania Posted: 13 Jun 2005 This is sobering news from a national health service that makes tough choices on balancing costs for AD medications with data on their long-term as well as short-term efficacy. View all comments by John Trojanowski Make a Comment To make a comment you must login or register.
Comments
University of Pennsylvania
This is sobering news from a national health service that makes tough choices on balancing costs for AD medications with data on their long-term as well as short-term efficacy.
Make a Comment
To make a comment you must login or register.